Trial intelligence / Profile preview

Moxifloxacin vs Ceftriaxone for Primary Pyogenic Liver Abscess

NCT00895089Phase 4Completed

Sponsor
Kaohsiung Veterans General Hospital
Start
May 2009
Primary completion
Dec 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of moxifloxacin in pyogenic liver abscess (PLA), sponsored by Kaohsiung Veterans General Hospital. Started May 2009; status: completed.

02

Drugs

moxifloxacin
03

Conditions

pyogenic liver abscess (PLA)

Beyond the preview

Go deeper on NCT00895089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00895089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call